Chris Erickson Named COO At Syner-G And Sequoia, Strengthening Leadership For Growth and Innovation

Syner-G BioPharma Group (Syner-G) and Sequoia Biotech Consulting (Sequoia), providers of integrated life science services, have appointed Chris Erickson as their new Chief Operating Officer (COO). With extensive experience in pharmaceutical services, Erickson is expected to play a key role in strengthening the companies' operations and expanding their market presence. As Syner-G and Sequoia continue maintaining their market leadership, Erickson’s appointment reinforces their commitment to operational excellence and strategic growth. 

 Ron Kraus, CEO, said in a statement, “We are thrilled to welcome Chris to the Syner-G & Sequoia leadership team. His deep expertise in pharmaceutical services, strategic mindset, and proven ability to drive operational excellence make him an invaluable asset to our organisation. As we continue to grow and expand our capabilities, Chris’ leadership will be crucial in ensuring we deliver exceptional value to our clients and partners.” 

With more than two decades of experience in the industry, Erickson proved his ability to enhance global operations and grow the customer base through a customer-centric approach. The former Chief Commercial Officer at Cytel achieved rapid company growth by leading the expansion of consulting services and enhancing software capabilities and operations management areas. He led crucial efforts in acquiring and integrating multiple companies at Cytel. Erickson spent around two decades at PAREXEL, leading the Real-World Evidence Solutions business throughout the global network to generate sustainable profit and revenue growth exceeding ten per cent.

“I am honoured to join Syner-G & Sequoia at such a pivotal time in its growth journey. The company’s commitment to innovation, customer success, and operational excellence aligns perfectly with my values and experience. I look forward to working alongside this talented team to drive strategic initiatives and deliver outstanding solutions for our clients,” said Mr. Erickson.